Form D · Biotechnology
Early Detection Inc.
Newport News, VA · CIK 0001836597
Offering snapshot reported Mar 17, 2023 · SEC filing
- Reported sold
- $25K Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 1, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 17, 2023 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Sep 3, 2021 | Initial | $257,000 | No comparison | Not reported | SEC filing |
| Dec 23, 2020 | Initial | $80,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-476133
Source: Form D, filed Mar 17, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark A. Chapman | Director, Executive |
| Bryan Joy | Executive |
| Gary Mc Adam | Director, Promoter |
| Abul Kalam Shamsuddin | Director, Executive |
| Kim Vanderlinden | Director, Executive |
| Kim Vinderlinden | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
732 Thimble Shoals Ste 302 A #1051
Newport News, VA, 23606
Newport News, VA, 23606